rs201691359

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002473.6(MYH9):​c.769+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000317 in 1,612,878 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00045 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 2 hom. )

Consequence

MYH9
NM_002473.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.31

Publications

1 publications found
Variant links:
Genes affected
MYH9 (HGNC:7579): (myosin heavy chain 9) This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
MYH9 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • May-Hegglin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 22-36321743-G-A is Benign according to our data. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36321743-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 178437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000446 (68/152320) while in subpopulation AMR AF = 0.00176 (27/15300). AF 95% confidence interval is 0.00124. There are 1 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 68 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH9NM_002473.6 linkc.769+15C>T intron_variant Intron 7 of 40 ENST00000216181.11 NP_002464.1 P35579-1A0A024R1N1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH9ENST00000216181.11 linkc.769+15C>T intron_variant Intron 7 of 40 1 NM_002473.6 ENSP00000216181.6 P35579-1

Frequencies

GnomAD3 genomes
AF:
0.000453
AC:
69
AN:
152202
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000465
AC:
117
AN:
251488
AF XY:
0.000427
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000536
Gnomad OTH exome
AF:
0.00195
GnomAD4 exome
AF:
0.000303
AC:
443
AN:
1460558
Hom.:
2
Cov.:
31
AF XY:
0.000312
AC XY:
227
AN XY:
726686
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33450
American (AMR)
AF:
0.00127
AC:
57
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000255
AC:
22
AN:
86218
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53396
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5766
European-Non Finnish (NFE)
AF:
0.000279
AC:
310
AN:
1110844
Other (OTH)
AF:
0.000514
AC:
31
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000446
AC:
68
AN:
152320
Hom.:
1
Cov.:
33
AF XY:
0.000416
AC XY:
31
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41564
American (AMR)
AF:
0.00176
AC:
27
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000287
Hom.:
0
Bravo
AF:
0.000684
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 24, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 23, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.769+15C>T in intron 07 of MYH9: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence and has been identified in 39/66728 of European chromosomes and in 16/1157 8 Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs201691359). -

Autosomal dominant nonsyndromic hearing loss 17 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Autosomal dominant nonsyndromic hearing loss 17;C5200934:Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss Benign:1
Nov 10, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MYH9-related disorder Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.071
DANN
Benign
0.73
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201691359; hg19: chr22-36717788; API